Skip to main content

Table 4 Prevalence and odds ratios (OR) with 95% confidence intervals of previously known type 2 diabetes (T2D), screen-detected type 2 diabetes (ST2D), total type 2 diabetes (TT2D), impaired glucose tolerance (IGT), impaired fasting glucose (IFG), abnormal glucose tolerance (AGT = TT2D, IGT or IFG) of the study sample by waist circumference and gender

From: High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population

 

MEN

WOMEN

 

WAIST CIRCUMFERENCE (cm)

WAIST CIRCUMFERENCE (cm)

 

< 94

94–101

= 102

p*

< 80

80–87

= 88

p*

n

427

437

500

 

351

355

755

 

T2D, %

2.1

5.5

15.2

< 0.001

2.0

2.5

6.9

< 0.001

OR

1.0 (ref)

2.50

(1.14–5.47)

7.92

(3.89–16.11)

 

1.0 (ref)

1.20

(0.44–3.28)

3.12

(1.39–6.98)

 

ST2D, %

5.2

7.8

14.0

< 0.001

2.3

3.7

11.8

< 0.001

OR

1.0 (ref)

1.46

(0.83–2.55)

2.69

(1.63–4.46)

 

1.0 (ref)

1.56

(0.63–3.82)

5.00

(2.39–10.49)

 

TT2D, %

7.3

13.3

29.2

< 0.001

4.3

6.2

18.7

< 0.001

OR

1.0 (ref)

1.82

(1.14–2.89)

4.93

(3.24–7.51)

 

1.0 (ref)

1.40

(0.71–2.77)

4.48

(2.57–7.80)

 

IGT, %

9.6

18.1

19.6

< 0.001

8.8

15.2

21.2

< 0.001

OR

1.0 (ref)

1.92

(1.28–2.90)

2.01

(1.35–3.00)

 

1.0 (ref)

1.82

(1.13–2.93)

2.50

(1.65–3.79)

 

IFG, %

6.3

8.0

13.2

< 0.001

0.9

4.8

6.8

< 0.001

OR

1.0 (ref)

1.36

(0.80–2.29)

2.46

(1.53–3.96)

 

1.0 (ref)

5.97

(1.73–20.57)

8.71

(2.69–28.20)

 

AGT, %

23.2

39.4

62.0

< 0.001

14.0

26.2

46.6

< 0.001

OR

1.0 (ref)

2.05

(1.51–2.79)

5.23

(3.87–7.05)

 

1.0 (ref)

2.18

(1.47–3.23)

5.02

(3.56–7.08)

 
  1. *Likelihood-ratio test of equality, adjusted for age. †Age and geographical area adjusted odds ratios including 95% confidence interval of odds ratios.